# Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade

> clinical trial · VERIFIED · 2026-07-30

Status: ACTIVE_NOT_RECRUITING · Sponsor: Emory University · Condition: Metastatic Non-Small Lung Cell Cancer

- Company: Emory University
- Sector: Metastatic Non-Small Lung Cell Cancer
- Primary source: https://clinicaltrials.gov/study/NCT04340882

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.